Ou Jiang

1.6k total citations
37 papers, 624 citations indexed

About

Ou Jiang is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ou Jiang has authored 37 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Ou Jiang's work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (5 papers) and MicroRNA in disease regulation (4 papers). Ou Jiang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (5 papers) and MicroRNA in disease regulation (4 papers). Ou Jiang collaborates with scholars based in China, United States and Australia. Ou Jiang's co-authors include Wei Zhi, Fanzhi Meng, Xiong Lu, Kefeng Wang, Chaoming Xie, Liming Fang, Hongping Zhang, Yaguang Weng, Jing Zhu and Jie Tian and has published in prestigious journals such as Neuron, Cancer and ACS Applied Materials & Interfaces.

In The Last Decade

Ou Jiang

28 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ou Jiang China	13	232	201	122	88	82	37	624
Hailong He China	17	215 0.9×	204 1.0×	66 0.5×	48 0.5×	233 2.8×	79	891
Linyang Chu China	15	347 1.5×	238 1.2×	76 0.6×	56 0.6×	247 3.0×	20	906
Kristin Andreas Germany	13	257 1.1×	211 1.0×	50 0.4×	43 0.5×	177 2.2×	15	1.0k
Erika M. J. Siren Canada	9	143 0.6×	306 1.5×	59 0.5×	37 0.4×	194 2.4×	12	802
Christopher J. Pino United States	14	202 0.9×	203 1.0×	28 0.2×	43 0.5×	153 1.9×	38	624
Kazutoshi Iijima Japan	18	217 0.9×	200 1.0×	21 0.2×	46 0.5×	57 0.7×	70	779
О. Г. Хазиахматова Russia	13	152 0.7×	134 0.7×	38 0.3×	66 0.8×	66 0.8×	76	498
Anting Jin China	10	235 1.0×	270 1.3×	78 0.6×	71 0.8×	59 0.7×	22	669

Countries citing papers authored by Ou Jiang

Since Specialization

Citations

This map shows the geographic impact of Ou Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ou Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ou Jiang more than expected).

Fields of papers citing papers by Ou Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ou Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ou Jiang. The network helps show where Ou Jiang may publish in the future.

Co-authorship network of co-authors of Ou Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ou Jiang. A scholar is included among the top collaborators of Ou Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ou Jiang. Ou Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Shan, Yi Jin, Xuan Huang, et al.. (2025). LBA83 RC118 (CLDN18.2-targeted ADC) combined with PD-1 blockade or RC148 (PD-1/VEGF bispecific antibody) for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (la/m G/GEJA). Annals of Oncology. 36. S1625–S1625.

Jiang, Ou, et al.. (2024). A retarded foam acid fluid system for low-temperature dolomite geothermal reservoir stimulation and its action mechanisms. Colloids and Surfaces A Physicochemical and Engineering Aspects. 705. 135717–135717. 2 indexed citations

Jiang, Ou, et al.. (2024). Research on mass transfer mechanisms due to short-term water-rock interactions between granite cuttings and alkaline NaCl solution and their patterns. Geoenergy Science and Engineering. 245. 213512–213512. 1 indexed citations

Chen, Long, Ou Jiang, Hong Ge, et al.. (2024). TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial. Translational Lung Cancer Research. 13(10). 2828–2837.

Jiang, Ou, et al.. (2024). Review of Reservoir Damage Mechanisms Induced by Working Fluids and the Design Principles of Reservoir Protection Fluids: From Oil–Gas Reservoirs to Geothermal Reservoirs. Energies. 17(19). 4895–4895. 1 indexed citations

Zheng, Yulong, Jianqing Zhu, Jianping Xiong, et al.. (2024). Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death‐1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105‐204). Cancer. 130(12). 2180–2190. 2 indexed citations

Li, Xiaoyu, Ou Jiang, Mo Chen, & Songlin Wang. (2024). Mitochondrial homeostasis: shaping health and disease. 3(1). 18 indexed citations

Hu, Xingjiang, Qingfu Zhang, Tao Sun, et al.. (2023). LBA5 Capivasertib (C) + fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Phase III CAPItello-291 trial Chinese cohort. Annals of Oncology. 34. S1485–S1486.

Zheng, Yulong, Anna Rachelle Mislang, Jermaine Coward, et al.. (2022). Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers. Cancer Immunology Immunotherapy. 71(10). 2371–2379. 14 indexed citations

10.

Wu, Yi‐Long, Qing Zhou, Ou Jiang, et al.. (2021). LBA43 GEMSTONE-301: A randomized, double-blind, placebo-controlled, phase III study of sugemalimab in patients with unresectable stage III non-small cell lung cancer (NSCLC) who had not progressed after concurrent or sequential chemoradiotherapy (CRT). Annals of Oncology. 32. S1321–S1321. 4 indexed citations

11.

Zhou, Qing, Ming Chen, Gang Wu, et al.. (2020). GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/ unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy. Translational Lung Cancer Research. 9(5). 2008–2015. 8 indexed citations

12.

Jiang, Ou, et al.. (2016). Negative short-term impact of intraoperative biliary lavage in patients with hepatolithiasis. World Journal of Gastroenterology. 22(11). 3234–3234.

13.

Yang, Ge, Ou Jiang, Xiaoyue Jiang, et al.. (2015). MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5. Molecular Medicine Reports. 12(3). 3930–3936. 30 indexed citations

14.

Han, Lu, Hong Lin, Xiong Lu, et al.. (2014). BMP2-encapsulated chitosan coatings on functionalized Ti surfaces and their performance in vitro and in vivo. Materials Science and Engineering C. 40. 1–8. 42 indexed citations

15.

Jiang, Ou, et al.. (2013). Clinical Significance of Spleen–Remnant Liver Volume Ratio in Hepatocellular Carcinoma Surgery. Indian Journal of Surgery. 77(S3). 811–815. 1 indexed citations

16.

Ge, Yang, Jing Zhu, Ou Jiang, et al.. (2013). Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Oncology Reports. 30(2). 877–889. 83 indexed citations

17.

Jiang, Ou, et al.. (2013). CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis. Tumor Biology. 34(2). 1215–1224. 19 indexed citations

18.

Zhou, Chao, et al.. (2005). Comparison of the survival of human biopsied embryos after cryopreservation with four different methods using non-transferable embryos. Human Reproduction. 20(6). 1615–1618. 61 indexed citations

19.

Jiang, Ou. (2002). Genetic diversity of Chinese Yak.

20.

Buetow, Kenneth H., Darryl Nishimura, Phil Green, et al.. (1990). A detailed multipoint gene map of chromosome 1q. Genomics. 8(1). 13–21. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact